AstraZeneca Pharmaceuticals LP
CALQUENCE® (acalabrutinib) plus chemoimmunotherapy reduced the risk of[...]
Regeneron Pharmaceuticals Inc.
Updated Linvoseltamab Data Showcase Continued Deepening of Responses in[...]
05/23/2024 | Press release | Distributed by Public on 05/23/2024 08:34
Please select the service you want to use:
Smartlinks | USAA Mutual Funds Trust | Company News | Financial Services | Investment Funds | Mutual Funds | Investment Services | Private Companies | Mutual Funds
Back
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact